Date: 24.6.2011
A study conducted by researchers at Karolinska Institutet's Department of Molecular Medicine and Surgery presents a possible method of delaying the disease.
Type I diabetes coincides with high blood concentrations of the lipoprotein apolipoprotein CIII (ApoCIII). The team has now demonstrated on rats, which develop a form of type I diabetes analogous to the human kind, that levels of Apo CIII are raised before the onset of the disease and that this causes the insulin producing beta cells to die.
By reducing the production of ApoCIII using antisense therapy, the researchers succeeded in significantly delaying the onset of diabetes to the extent that it took twice as long for the rats to develop the disease.
Source:
http://ki.se/ki/jsp/polopoly.jsp?d=130&a=124361&l=en&newsdep=130
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Charles University - Charles University in Prague
Biotechnology Journals - Plant, environmetal, animal biotechnology journals
Vibrio natriegens: Low-cost microbe could speed biological discovery
Traces of DNA in the stomachs of predatory snails provide new insights into the ecology of placozoans